For example dogs with a spontaneous mutation in the Rpe65 gene were pivotal in the development of phase I/II clinical trial programs for treatment of patients with mutations in the RPE65 gene, an important cause of LCA [5]. This evidence concerns the gene RPE65 and Leber congenital amaurosis.